Hormonal contraception in overweight or obese women
31 results
1 - 31
Women who use levonorgestrel-releasing intrauterine devices are less likely to develop ischemic stroke than nonusers of hormonal contraception- Certain hormonal contraceptives increase thromboembolism risk when taken with NSAIDs
- High continuation of contraceptive ring vs patch
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Oral contraceptives increase risk of thrombotic stroke and MI
- Levonorgestrel is ineffective emergency contraception for obese women
- Modern hormonal contraception associated with increased risk of breast cancer
- Bariatric surgery associated with resolution of endometrial hyperplasia
- Long-acting contraceptive methods effective longer than approved duration
- DMPA associated with reduced risk for ovarian cancer
- Female hormone therapy is not associated with an increased risk of retinal artery or vein occlusion
- Contraceptive implant and LNG-IUD both reduce pelvic pain associated with endometriosis
- Duration of vasomotor symptoms can be quite long during menopause
- Elagolix with add-back therapy effective for premenopausal heavy menstrual bleeding associated with fibroids
- Prophylactic salpingo-oophorectomy reduces ovarian cancer risk
- Migraine with aura associated with increased risk of CVD in women
- Levonorgestrel-releasing IUS effective for menorrhagia
- OC use associated with reduction in ovarian cancer risk
- Gabapentin ineffective for vulvodynia
- Elagolix reduces pain but increases hot flushes/LDL and decreases BMD in women with mod-severe endometriosis
- Saffron promising for treatment of PMS
- AHA/ACC guideline for the primary prevention of stroke